Trial Profile
Effect of Pregabalin in Patients With Radiotherapy-Related Neuropathic Pain: a Randomized, Double-blind, Placebo-controlled Trial
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Pregabalin (Primary)
- Indications Neuropathic pain
- Focus Therapeutic Use
- 23 May 2018 Status changed from recruiting to completed.
- 18 Jun 2017 Planned number of patients changed from 128 to 138.
- 07 Jun 2017 Planned number of patients changed from 60 to 128.